[
  {
    "ts": null,
    "headline": "West Pharmaceutical Services (WST) Rebounded in Q3",
    "summary": "Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -0.88% (net) during the third quarter, underperforming the benchmark, the Russell 1000 Growth Index. Even though the portfolio has significant exposure to AI, its underweight to […]",
    "url": "https://finnhub.io/api/news?id=738259b68f6accf6d2ad03c8d03cc30f061a2832e73174909b5909a74432cc3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764855924,
      "headline": "West Pharmaceutical Services (WST) Rebounded in Q3",
      "id": 137679944,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -0.88% (net) during the third quarter, underperforming the benchmark, the Russell 1000 Growth Index. Even though the portfolio has significant exposure to AI, its underweight to […]",
      "url": "https://finnhub.io/api/news?id=738259b68f6accf6d2ad03c8d03cc30f061a2832e73174909b5909a74432cc3e"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons WST is Risky and 1 Stock to Buy Instead",
    "summary": "West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=c166cdf2df968d87087a721de8241183217a33e2fc587edbe5add8f707f0aa55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764820916,
      "headline": "3 Reasons WST is Risky and 1 Stock to Buy Instead",
      "id": 137679946,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=c166cdf2df968d87087a721de8241183217a33e2fc587edbe5add8f707f0aa55"
    }
  }
]